Effect of Exclusive Enteral Nutrition on Health‐Related Quality of Life for Adults With Active Crohn's Disease
Authors:
- 12 July 2013
- journal article
- clinical trial
- Published by Wiley in Nutrition in Clinical Practice
- Vol. 28 (4) , 499-505
Abstract
Background: Exclusive enteral nutrition (EEN) is an effective and safe remission induction treatment for Crohn's disease in adults. Its influence on adults’ health‐related quality of life remains unknown. The aim of this study was to determine the effect of EEN on health‐related quality of life in adults with active Crohn's disease. Materials and Methods: Patients recruited were treated with a polymeric enteral feed that was taken orally in the daytime and via a self‐intubated nasogastric tube at night for 4 weeks. Prospective evaluation of disease activity (Crohn's Disease Activity Index, CDAI) and health‐related quality of life (Inflammatory Bowel Disease Questionnaire, IBDQ) were performed at enrollment and after 4 weeks of treatment. Patients’ feelings about EEN were also investigated through 2 questions. Results: Thirteen patients were treated with 4‐week EEN. They had a significant improvement in total IBDQ score (P < .001) and all IBDQ dimensions: bowel symptoms (P < .001), systemic symptoms (P < .001), social function (P = .003), and emotional status (P < .001), with 11 patients (84.6%) achieving clinical remission after treatment. In addition, 8 patients (61.5%) expressed their willingness to receive this 4‐week EEN treatment again to induce remission if the disease relapsed. The IBDQ correlated significantly with the CDAI at 4 weeks. Conclusions: A 4‐week treatment of EEN improves health‐related quality of life significantly in adults with active Crohn's disease and was acceptable by most patients.Keywords
This publication has 26 references indexed in Scilit:
- An update of the role of nutritional therapy in the management of Crohn’s diseaseJournal of Gastroenterology, 2012
- Enteral nutrition decreases hospitalization rate in patients with Crohn's diseaseJournal of Gastroenterology and Hepatology, 2010
- Prospective assessment of the effect on quality of life of anti‐tumour necrosis factor therapy for perineal Crohn’s fistulasAlimentary Pharmacology & Therapeutics, 2009
- Quality of life of patients and medical cost of “half elemental diet” as maintenance therapy for Crohn’s disease: Secondary outcomes of a randomised controlled trialDigestive and Liver Disease, 2009
- Enteral nutrition in adult Crohn's disease: Present status and perspectivesMolecular Nutrition & Food Research, 2008
- Nutrition and adult inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics, 2003
- Impact of Inflammatory Bowel Disease on Health-Related Quality of LifeDigestive Diseases, 1999
- Initial response and subsequent course of Crohn's disease treated with elemental diet or prednisolone.Gut, 1993
- Polymeric enteral diets as primary treatment of active Crohn's disease: a prospective steroid controlled trial.Gut, 1993
- A Randomized Prospective Trial Comparing a Defined Formula Diet, Corticosteroids, and a Defined Formula Diet Plus Corticosteroids in Active Crohn's DiseaseMayo Clinic Proceedings, 1992